Biocon
Makarand Gadekar is an experienced professional in the pharmaceutical industry with a career spanning several decades. Currently serving as Vice President of API Projects at Cadila Pharmaceuticals Limited since September 2022, Makarand has held notable positions such as GM of Projects at Biocon since March 2019, and GM of Projects at Sun Pharma from February 2015 to February 2019. Previous roles include Associate Director at Dr. Reddy's Lab, and Sr. Manager of Engineering at Sandoz Pvt Ltd. Makarand commenced a career in engineering at Boehringer Mannheim India Ltd as an Assistant Manager and progressed to roles of increasing responsibility at Hoechst Marion Roussel. Makarand holds a B.E. degree and a Master's in Administration Management from the University of Mumbai, completed between 1990 and 1993.
This person is not in any teams
This person is not in any offices
Biocon
22 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.